Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals

Molecular Therapy Methods and Clinical Development

Volumn 1, Issue , 2014, Pages 14010-

  Pridans, Clare ^a   Lillico, Simon ^a   Whitelaw, Bruce ^a   Hume, David A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84905470556     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2014.10     Document Type: Article

References (43)

1. Pollard, JW (2009). Trophic macrophages in development and disease. Nat Rev Immunol 9: 259-270.
2. Williams, HJ, Fisher, EA and Greaves, DR (2012). Macrophage differentiation and function in atherosclerosis: opportunities for therapeutic intervention? J Innate Immun 4: 498-508.
3. Kinne, RW, Bräuer, R, Stuhlmüller, B, Palombo-Kinne, E and Burmester, GR (2000). Macrophages in rheumatoid arthritis. Arthritis Res 2: 189-202.
4. Richards, DM, Hettinger, J and Feuerer, M (2013). Monocytes and macrophages in cancer: development and functions. Cancer Microenviron 6: 179-191.
5. Biju, KC, Santacruz, RA, Chen, C, Zhou, Q, Yao, J, Rohrabaugh, SL et al. (2013). Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease. Neurosci Lett 535: 24-29.
6. Steinman, RM and Inaba, K (1988). The binding of antigen presenting cells to T lymphocytes. Adv Exp Med Biol 237: 31-41.
7. Steinman, RM, Mellman, IS, Muller, WA and Cohn, ZA (1983). Endocytosis and the recycling of plasma membrane. J Cell Biol 96: 1-27.
8. Parenti, G, Pignata, C, Vajro, P and Salerno, M (2013). New strategies for the treatment of lysosomal storage diseases (review). Int J Mol Med 31: 11-20.
9. Rahman, FZ, Hayee, B, Chee, R, Segal, AW and Smith, AM (2009). Impaired macrophage function following bacterial stimulation in chronic granulomatous disease. Immunology 128: 253-259.
10. Brendel, C, Hänseler, W, Wohlgensinger, V, Bianchi, M, Tokmak, S, Chen-Wichmann, L et al. (2013). Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy. Hum Gene Ther Methods 24: 151-159.
11. Sasmono, RT and Williams, E (2012). Generation and characterization of MacGreen mice, the Cfs1r-EGFP transgenic mice. Methods Mol Biol 844: 157-176.
12. Sasmono, RT, Oceandy, D, Pollard, JW, Tong, W, Pavli, P, Wainwright, BJ et al. (2003). A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 101: 1155-1163.
13. Sauter, KA, Bouhlel, MA, O'Neal, J, Sester, D P, Tagoh, H, Ingram, RM et al. (2013). The function of the conserved regulatory element within the second intron of the mammalian Csf1r locus. PLoS One 8: e54935.
14. Himes, SR, Tagoh, H, Goonetilleke, N, Sasmono, T, Oceandy, D, Clark, R et al. (2001). A highly conserved c-fms gene intronic element controls macrophage-specific and regulated expression. J Leukoc Biol 70: 812-820.
15. Cecchini, MG, Dominguez, MG, Mocci, S, Wetterwald, A, Felix, R, Fleisch, H et al. (1994). Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120: 1357-1372.
16. Dai, XM, Ryan, GR, Hapel, AJ, Dominguez, MG, Russell, RG, Kapp, S et al. (2002). Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99: 111-120.
17. Yue, X, Favot, P, Dunn, TL, Cassady, AI and Hume, DA (1993). Expression of mRNA encoding the macrophage colony-stimulating factor receptor (c-fms) is controlled by a constitutive promoter and tissue-specific transcription elongation. Mol Cell Biol 13: 3191-3201.
18. Lois, C, Hong, EJ, Pease, S, Brown, EJ and Baltimore, D (2002). Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868-872.
19. Pluta, K and Kacprzak, MM (2009). Use of HIV as a gene transfer vector. Acta Biochim Pol 56: 531-595.
20. Kumar, M, Keller, B, Makalou, N and Sutton, RE (2001). Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 12: 1893-1905.
21. Boutin, JA (1997). Myristoylation. Cell Signal 9: 15-35.
22. Pelchen-Matthews, A, Kramer, B and Marsh, M (2003). Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 162: 443-455.
23. Pieters, J (2001). Entry and survival of pathogenic mycobacteria in macrophages. Microbes Infect 3: 249-255.
24. Follows, GA, Tagoh, H, Richards, SJ, Melnik, S, Dickinson, H, de Wynter, E et al. (2005). c-FMS chromatin structure and expression in normal and leukaemic myelopoiesis. Oncogene 24: 3643-3651.
25. Biffi, A, Lucchini, G, Rovelli, A and Sessa, M (2008). Metachromatic leukodystrophy: an overview of current and prospective treatments. Bone Marrow Transplant 42 (suppl. 2): S2-S6.
26. Biffi, A, Montini, E, Lorioli, L, Cesani, M, Fumagalli, F, Plati, T et al. (2013). Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341: 1233158.
27. Hume, DA (2011). Applications of myeloid-specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunit y. J Leukoc Biol 89: 525-538.
28. He, W, Qiang, M, Ma, W, Valente, AJ, Quinones, M P, Wang, W et al. (2006). Development of a synthetic promoter for macrophage gene therapy. Hum Gene Ther 17: 949-959.
29. Levin, MC, Lidberg, U, Jirholt, P, Adiels, M, Wramstedt, A, Gustafsson, K et al. (2012). Evaluation of macrophage-specific promoters using lentiviral deliver y in mice. Gene Ther 19: 1041-1047.
30. Pillai, MM, Hayes, B and Torok-Storb, B (2009). Inducible transgenes under the control of the hCD68 promoter identifies mouse macrophages with a distribution that differs from the F4/80-and CSF-1R-expressing populations. Exp Hematol 37: 1387-1392.
31. Hirsch, S, Austyn, JM and Gordon, S (1981). Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture. J Exp Med 154: 713-725.
32. Michelini, Z, Negri, D and Cara, A (2010). Integrase defective, nonintegrating lentiviral vectors. Methods Mol Biol 614: 101-110.
33. Leavitt, AD, Robles, G, Alesandro, N and Varmus, HE (1996). Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol 70: 721-728.
34. Hu, B, Tai, A and Wang, P (2011). Immunization delivered by lentiviral vectors for cancer and infectious diseases. Immunol Rev 239: 45-61.
35. Hu, B, Dai, B and Wang, P (2010). Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity. Vaccine 28: 6675-6683.
36. Gottlieb, P, Utz, PJ, Robinson, W and Steinman, L (2013). Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform. Clin Immunol 149: 297-306.
37. MacDonald, K P, Rowe, V, Bofinger, HM, Thomas, R, Sasmono, T, Hume, DA et al. (2005). The colony-stimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansion. J Immunol 175: 1399-1405.
38. Hill, AV (2011). Vaccines against malaria. Philos Trans R Soc Lond B Biol Sci 366: 2806-2814.
39. Larina, IV, Shen, W, Kelly, OG, Hadjantonakis, AK, Baron, MH and Dickinson, ME (2009). A membrane associated mCherry fluorescent reporter line for studying vascular remodeling and cardiac function during murine embryonic development. Anat Rec (Hoboken) 292: 333-341.
40. Kapetanovic, R, Fairbairn, L, Beraldi, D, Sester, DP, Archibald, AL, Tuggle, CK et al. (2012). Pig bone marrow-derived macrophages resemble human macrophages in their response to bacterial lipopolysaccharide. J Immunol 188: 3382-3394.
41. Wang, Y, Zhou, X, Lin, J, Yin, F, Xu, L, Huang, Y et al. (2011). Effects of Mycobacterium bovis on monocyte-derived macrophages from bovine tuberculosis infection and healthy cattle. FEMS Microbiol Lett 321: 30-36.
42. Schroder, K, Irvine, KM, Taylor, MS, Bokil, NJ, Le Cao, KA, Masterman, KA et al. (2012). Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc Natl Acad Sci USA 109: E944-E953.
43. Fach, SJ, Olivier, A, Gallup, JM, Waters, TE, Ackermann, MR, Lehmkuhl, HD et al. (2010). Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation. Vet Immunol Immunopathol 136: 55-64.